Phio Pharmaceuticals
PHIO
#10919
Rank
C$15.28 M
Marketcap
C$1.32
Share price
-5.80%
Change (1 day)
-57.02%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -C$18.03 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$12.41 Million a decrease over its 2024 earnings that were of -C$10.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$18.03 Million45.22%
2025 -C$12.41 Million21.65%
2024 -C$10.21 Million-33.96%
2023 -C$15.45 Million-5.7%
2022 -C$16.38 Million-13.6%
2021 -C$18.96 Million51.09%
2020 -C$12.55 Million-1.28%
2019 -C$12.71 Million21.03%
2018 -C$10.51 Million-53.1%
2017 -C$22.4 Million74.49%
2016 -C$12.84 Million-12.02%
2015 -C$14.59 Million16.17%
2014 -C$12.56 Million-57.95%
2013 -C$29.86 Million62.45%
2012 -C$18.38 Million0.87%
2011 -C$18.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.12 Billion 518.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.91 Million 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA